NM_080424.4:c.1568T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_080424.4(SP110):​c.1568T>C​(p.Met523Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.469 in 1,612,900 control chromosomes in the GnomAD database, including 183,714 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13277 hom., cov: 32)
Exomes 𝑓: 0.48 ( 170437 hom. )

Consequence

SP110
NM_080424.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.542

Publications

50 publications found
Variant links:
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
SP110 Gene-Disease associations (from GenCC):
  • hepatic veno-occlusive disease-immunodeficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.4625439E-5).
BP6
Variant 2-230177560-A-G is Benign according to our data. Variant chr2-230177560-A-G is described in ClinVar as Benign. ClinVar VariationId is 334902.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.502 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_080424.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
NM_080424.4
MANE Select
c.1568T>Cp.Met523Thr
missense
Exon 14 of 19NP_536349.3Q9HB58-6
SP110
NM_001378442.1
c.1586T>Cp.Met529Thr
missense
Exon 15 of 20NP_001365371.1
SP110
NM_001378443.1
c.1568T>Cp.Met523Thr
missense
Exon 14 of 19NP_001365372.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
ENST00000258381.11
TSL:2 MANE Select
c.1568T>Cp.Met523Thr
missense
Exon 14 of 19ENSP00000258381.6Q9HB58-6
SP110
ENST00000358662.9
TSL:1
c.1568T>Cp.Met523Thr
missense
Exon 14 of 18ENSP00000351488.4Q9HB58-1
SP110
ENST00000258382.10
TSL:1
c.1568T>Cp.Met523Thr
missense
Exon 14 of 15ENSP00000258382.5Q9HB58-3

Frequencies

GnomAD3 genomes
AF:
0.399
AC:
60683
AN:
151992
Hom.:
13273
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.243
Gnomad AMI
AF:
0.565
Gnomad AMR
AF:
0.374
Gnomad ASJ
AF:
0.518
Gnomad EAS
AF:
0.169
Gnomad SAS
AF:
0.421
Gnomad FIN
AF:
0.402
Gnomad MID
AF:
0.494
Gnomad NFE
AF:
0.506
Gnomad OTH
AF:
0.417
GnomAD2 exomes
AF:
0.419
AC:
105350
AN:
251440
AF XY:
0.430
show subpopulations
Gnomad AFR exome
AF:
0.236
Gnomad AMR exome
AF:
0.292
Gnomad ASJ exome
AF:
0.523
Gnomad EAS exome
AF:
0.154
Gnomad FIN exome
AF:
0.411
Gnomad NFE exome
AF:
0.515
Gnomad OTH exome
AF:
0.443
GnomAD4 exome
AF:
0.476
AC:
695138
AN:
1460788
Hom.:
170437
Cov.:
39
AF XY:
0.476
AC XY:
345962
AN XY:
726768
show subpopulations
African (AFR)
AF:
0.235
AC:
7867
AN:
33470
American (AMR)
AF:
0.302
AC:
13506
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.518
AC:
13528
AN:
26130
East Asian (EAS)
AF:
0.169
AC:
6701
AN:
39668
South Asian (SAS)
AF:
0.420
AC:
36262
AN:
86244
European-Finnish (FIN)
AF:
0.411
AC:
21941
AN:
53410
Middle Eastern (MID)
AF:
0.500
AC:
2886
AN:
5768
European-Non Finnish (NFE)
AF:
0.509
AC:
565036
AN:
1111012
Other (OTH)
AF:
0.454
AC:
27411
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
20246
40492
60739
80985
101231
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16090
32180
48270
64360
80450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.399
AC:
60710
AN:
152112
Hom.:
13277
Cov.:
32
AF XY:
0.392
AC XY:
29179
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.243
AC:
10087
AN:
41522
American (AMR)
AF:
0.373
AC:
5709
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.518
AC:
1797
AN:
3468
East Asian (EAS)
AF:
0.170
AC:
876
AN:
5160
South Asian (SAS)
AF:
0.420
AC:
2028
AN:
4824
European-Finnish (FIN)
AF:
0.402
AC:
4248
AN:
10572
Middle Eastern (MID)
AF:
0.490
AC:
143
AN:
292
European-Non Finnish (NFE)
AF:
0.506
AC:
34425
AN:
67968
Other (OTH)
AF:
0.419
AC:
884
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1811
3623
5434
7246
9057
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
578
1156
1734
2312
2890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.471
Hom.:
39227
Bravo
AF:
0.389
TwinsUK
AF:
0.513
AC:
1903
ALSPAC
AF:
0.499
AC:
1924
ESP6500AA
AF:
0.255
AC:
1124
ESP6500EA
AF:
0.501
AC:
4306
ExAC
AF:
0.426
AC:
51677
Asia WGS
AF:
0.279
AC:
973
AN:
3478
EpiCase
AF:
0.510
EpiControl
AF:
0.516

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Hepatic veno-occlusive disease-immunodeficiency syndrome (3)
-
-
2
not specified (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.36
DANN
Benign
0.28
DEOGEN2
Benign
0.086
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.0044
T
MetaRNN
Benign
0.000025
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.85
N
PhyloP100
-0.54
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.59
N
REVEL
Benign
0.15
Sift
Benign
0.28
T
Sift4G
Benign
0.24
T
Polyphen
0.0
B
Vest4
0.040
MPC
0.15
ClinPred
0.017
T
GERP RS
-0.78
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.033
gMVP
0.51
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1135791; hg19: chr2-231042276; COSMIC: COSV51247578; COSMIC: COSV51247578; API